by
Irina Vetter
Pain is a major medical and socio-economic issue affecting one in five Australians. Our research aims to understand the molecular mechanisms behind pain. The current focus of the lab is to use toxins from plants and venomous animals to understand the molecular pharmacology of pain. These toxins are highly selective for ion channels and receptors found in the sensory neurons that detect pain and can potentially be developed into novel analgesics. Our research also investigates the mechanisms contributing to chemotherapy-induced pain, cancer-associated pain, inflammatory and neuropathic pain, and the painful marine toxin disease known as ciguatera. To investigate the neuropharmacology of pain we use a range of techniques including: in vivo pain pathway characterisation, high-content imaging of cultured sensory neurons, high-throughput screening using calcium and membrane potential assays, and traditional pharmacological assays. While all pain has similar symptoms, it is becoming clear that the underlying mechanisms behind pain can vary. Our research has already challenged traditional understanding of pain pathways and sensory neuronal physiology. We work in collaboration with other leading Australian and international researchers to identify novel therapeutic pain pathways and targets. By uncovering these new pain pathways, as well as identifying novel targets on peripheral sensory neurons, we aim to develop more effective pain therapies that treat the underlying cause of the pain, not just the symptoms.
“Health

Burns are one of the most common injuries, affecting as many as 200,000 Australians each year.


Hits: 37

by
Anita Milicic
Our main research focus is on developing a new vaccine encapsulation technology with the aim of reducing the number of immunisations required for full protection against a disease.
“Why

Facebook co-founder Mark Zuckerberg recently posted a photo on the social networking site of his two-month-old daughter in the doctor’s surgery waiting to be vaccinated.


Hits: 56

by
Andrew Watterson
School Responsibilities: Director of Research Director of Centre for Public Health and Population Health Research and Head of the Occupational and Environmental Health Research Group Member of School Advisory Board
“Can

The debate about whether or not talcum powder causes ovarian cancer has rumbled on for decades.


Hits: 115

by
Garry Jennings
Garry Jennings is Adjunct Professor of Medicine, Monash University and was previously Director of Baker IDI Heart and Diabetes Institute. He is Past President of the Association of Australian Medical Research Institutes (AAMRI), and of the High Blood Pressure Research Council of Australia and Head, WHO Collaborating Centre for Research and Training in Cardiovascular Health. A cardiologist, he was previously Director of Cardiology at The Alfred Hospital, Melbourne and Chair of the Division of Medicine and remains active in clinical cardiology at The Alfred. In over 400 research publications he has reported discoveries on the mechanisms, prevention and treatment of cardiovascular disease especially with exercise, hypertension and sympathetic pathophysiology. He has published books on heart disease for the general public and is a regular media commentator on health and policy issues. He is Founder and Chair of Nucleus Network, a subsidiary of Baker IDI and a member of the Boards of National Heart Foundation of Australia, Research Australia and AAMRI, Trustee of the Asia Pacific Society of Hypertension and of the Foundation for High Blood Pressure Research and President of the 2012 International Society of Hypertension scientific meeting.
“Explainer:

Most people usually link the phrase "heart attack" with "massive"; something you are undisputedly aware of.


Hits: 146

by
Aubrey Cunnington
“Explainer:

It is well known that babies born naturally – read that as vaginally – are exposed to lots of beneficial bacteria known as microbiota when they travel down the birth canal.


Hits: 650